IMCR Immunocore Holdings plc
$31.96▲ +2.17%
Healthcare
Other
After hours
$31.96▲ +0.00%
Oct 27, 4:00 PM ET
Volume 314.1K
Avg Volume (10D) 573.8K
Key Metrics & Fundamentals
Market Cap
$1.65B
P/E Ratio
–
Div Yield
0.00%
52W Range
27.50 - 40.72
% vs 50 MA
-2.15%
% vs 200 MA
0.56%
RSI-14
55.8
MACD Histogram
+0.4400
Beta (1Y vs SPY)
0.57
Free Cash Flow
$15.14M
Gross Rev
$115.93M
Gross Profit
$114.84M
EBITDA
$4.14M
COGS
$1.09M
Operating Exp
$117.84M
Operating Income
-$3.00M
EBIT
-$3.00M
Pretax Income
-$514,000
Net Income
-$808,000
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
GeneDx Holdings And 2 Other Top Healthcare Stocks
Simply Wall St. · Oct 17, 2026 11:11 AM ET
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Top 3 Healthcare Stocks To Watch In October 2026
Simply Wall St. · Oct 10, 2026 10:17 AM ET
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Zacks · Sep 15, 2026 11:22 AM ET
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
GlobeNewswire · Sep 14, 2026 7:00 AM ET
Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?
Zacks · Aug 25, 2026 11:07 AM ET
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Zacks · Aug 10, 2026 11:39 AM ET
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story
Simply Wall St. · Aug 7, 2026 4:15 AM ET
Immunocore Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 3:04 PM ET
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...
GuruFocus.com · Aug 6, 2026 3:02 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IMCR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.